期刊文献+

骨软骨瘤继发肉瘤变临床病理分析 被引量:5

Clinicopathologic features of osteochondroma with malignant transformation
原文传递
导出
摘要 目的分析骨软骨瘤继发肉瘤变的临床、影像学、组织病理学和免疫表型特征。方法回顾上海交通大学附属第六人民医院1991—2008年间诊断的骨软骨瘤463例,其中单发性408例,多发性55例;重点分析11例骨软骨瘤继发肉瘤变病例的临床、影像学和组织学形态特点;采用免疫组织化学EnVision二步法检测7例骨软骨瘤肉瘤变组织及10例未发生肉瘤变组织中CK、波形蛋白、S-100蛋白、p53及c—mye蛋白表达。结果11例骨软骨瘤恶变病例其中5例为单发性(单发性恶变率1.2%),6例为多发性(多发性恶变率10.9%)。男女比例为10:1。肉瘤变的部位分别是股骨4例,胫骨3例,肱骨1例,髂骨3例,耻骨1例,其中1例是髂骨和股骨联合病变。肉瘤变患者平均就诊年龄39.8岁,未肉瘤变骨软骨瘤平均就诊年龄20.4岁。肿瘤在骨表面结节状生长,体积巨大,边界不清,软骨帽厚度〉1.5cm,有广泛钙化。恶变成分为周围型软骨肉瘤Ⅰ~Ⅱ级,肿瘤细胞侵及周围软组织,偶可累及髓腔。免疫组织化学标记结果显示肿瘤细胞表达波形蛋白和S-100蛋白。p53阳性表达见于其中2例肉瘤变的病例(2/7),未发生肉瘤变的病例未检测到p53阳性表达。结论骨软骨瘤肉瘤变大多继发于多发性病例,发病年龄通常在30岁以后,有明显的男性发病优势,临床病史长,肿瘤体积巨大,软骨帽厚,钙化明显,结节状生长浸润周围软组织。恶变成分主要是周围型高分化软骨肉瘤,预后较好。p53基因突变可能是恶变的分子机制之一。 Objective To investigate the clinicopathologic, radiological and immunohistochemical characteristics of osteoehondroma with malignant transformation. Methods The clinical data, radiological imagings and hematoxylineosin stained histologie sections were reviewed in 463 cases of osteochondroma diagnosed in Shanghai 6th Hospital from 1991 to 2008, including 11 cases with malignant transformation. Immunohistochemical two-step staining was used to detect CK, vimentin, S-100 protein, p53 and c-myc expression in seven cases of osteochondroma with malignant transformation and 10 cases without malignant transformation. The relevant literature was reviewed. Results Among the 11 cases with malignant transformation, five were single osteochondroma (5/408,1.2%), and six were multiple osteochondromas (6/55,10. 9% ). The male to female ratio was 10: 1. These 11 cases were derived from femur (4 cases) , tibia (3 cases), ilium (3 cases) , shoulder bone (1 case) and pubis (1 case). There was one case that showed malignant transformation in both the femur and ilium. The mean ages for the malignant and nonmalignant cases were 39.8 years and 20.4 years respectively. All the malignant cases showed large sized lesions with prominent calcification in the thick cartilage caps. The malignant component was low grade, peripheral chondrosarcoma ( grade Ⅰ - Ⅱ ). In some areas the tumor cells infiltrated the peripheral soft tissue and bone marrow. Of the seven cases with malignant transformation that had immunohistochemieal staining, all were positive for vimentin and S-100 protein; p53 protein was positive in 2 of 7 cases. Conclusions Malignant transformation of osteochondroma was usually encountered in multiple lesions. Most patients were more than 30 years old with a long clinical history and with a male predominance. These tumors showed thick cartilage caps with prominent calcification. The lobulated nature of the tumors was evident and they infiltrated the surrounding soft tissue. The sarcomatoid component was peripheral type, well differentiated chondrosarcoma, p53 mutation may explain part of the molecular mechanism in the malignant transformation.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2009年第9期609-613,共5页 Chinese Journal of Pathology
关键词 骨肿瘤 骨软骨瘤 软骨肉瘤 肿瘤抑制蛋白质P53 Bone neoplasms Osteochondroma Chondrosarcoma Tumor suppressor protein p53
  • 相关文献

参考文献11

  • 1Fletcher CD, Unni KK, Mertens F. World Health Organization classification of tumors. Pathology and genetics of tumours of soft tissue and bone. 2nd ed. Lyon: IARC Press, 2002: 234-236.
  • 2Porter DE, Simpson AH. The neoplastic pathogenesis of solitary and multiple osteochondromas. J Pathol, 1999, 188 (2) : 119- 125.
  • 3Unni KK, Inwards CY, Bridge JA, et al. AFIP atlas of tumor pathology. Tumors of the bones and joints. 4th ed. Washington D. C. : AFIP, 2005: 37-46.
  • 4Shah ZK, Peh WC, Wong Y, et al. Sarcomatous transformation in diaphyseal aclasis. Australas Radiol,2007, 51 (2) : 110-119.
  • 5Wuyts W, Van Hul W, De Boulle K, et al. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet, 1998, 62(2) : 346-354.
  • 6Vujic M, Bergman A, Romanus B, et al. Hereditary multiple and isolated sporadic exostoses in the same kindred: identification of the causative gene (EXT2) and detection of a new mutation, ntll2delAT, that distinguishes the two phenotypes. Int J Mol Med, 2004, 13(1): 47-52.
  • 7Hameetman L, David G, Yavas A, et al. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas. J Pathol, 2007, 211(4): 399-409.
  • 8Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science,1991, 253 (5015) : 49-53.
  • 9Oshiro Y, Chaturvedi V, Hayden D, et al. Altered p53 is associated with aggressive behavior of chondrosarcoma: a long term follow-up study. Cancer, 1998, 83 ( 11 ) : 2324-2334.
  • 10Terek RM, Healey JH, Garin-Chesa P, et al. p53 mutations in chondrosarcoma. Diagn Mol Pathol, 1998, 7 (1) : 51-56.

同被引文献45

  • 1蒋智铭,张惠箴,陈洁晴,刘亮.手足骨肿瘤和瘤样病变154例临床病理分析[J].中华病理学杂志,2003,32(5):417-421. 被引量:23
  • 2冯仕庭,孟悛非,黄兆民,张翎,李子平,范淼.长骨嗜酸性肉芽肿的影像分析[J].放射学实践,2006,21(5):514-516. 被引量:27
  • 3乔继红,代向党,王赢,史大鹏.长骨非骨化性纤维瘤的X线及CT表现与病理基础(附17例报告)[J].实用放射学杂志,2006,22(8):976-977. 被引量:6
  • 4刘子君 李瑞宗 等.骨肿瘤及瘤样病变12404例病例统计分析[J].中华骨科杂志,1986,6(3):162-162.
  • 5王正义.足躁外科学[M].北京:人民卫生出版社,2006:566.
  • 6Bottner F, Rod1 R, Kordish I, et al. Surgical treatment of symp- tomatic osteochondroma. A three-to eight-year follow-up study [J]. J Bone Joint Surg Br, 2003,85(8): 1161-1165.
  • 7Pierz KA, Stieber JR, Kasumi K, et al. Hereditary muhip|e exos- toses: one center,s experience and review of etiology [J]. Clin Orthop Relat Res, 2002,401 (1): 49-59.
  • 8杜联军,丁晓毅,颜凌,陆勇,刘晓薇,江浩,陈克敏.骨巨细胞瘤常见和典型的CT表现分析[J].实用放射学杂志,2007,23(8):1070-1073. 被引量:17
  • 9FletcherCD.UnniKK,MertensF.WHO世界卫生组织肿瘤分类及诊断标准系YO/软组织与骨肿瘤病理学和遗传学.程虹,译.北京:人民卫生出版社,2006:273-290.
  • 10Mario.Campanaccl.骨与软组织肿瘤[M].张湘生,张庆,译.长沙:科学技术出版社,1999:63-510.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部